CG Oncology, Inc. (CGON) › Operating Cash FlowCG Oncology, Inc. (CGON) — Operating Cash FlowAnnual figures by period end, from SEC filings.2023-12-31: -$45.68M2024-12-31: -$78.71M2025-12-31: -$132.35M-$132.35M2023-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$132.35M—2026-02-27From 2025-01-012024-12-31-$78.71M—2026-02-27From 2024-01-012023-12-31-$45.68M—2026-02-27From 2023-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)